276 related articles for article (PubMed ID: 17622629)
1. Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines.
Wehrle F; Renzullo S; Faust A; Beer M; Kaden V; Hofmann MA
J Gen Virol; 2007 Aug; 88(Pt 8):2247-2258. PubMed ID: 17622629
[TBL] [Abstract][Full Text] [Related]
2. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif.
von Rosen T; Rangelova D; Nielsen J; Rasmussen TB; Uttenthal Å
Vet Microbiol; 2014 Jun; 170(3-4):224-31. PubMed ID: 24629779
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of the Erns protein of classical swine fever virus in yeast and its application in an indirect enzyme-linked immunosorbent assay for antibody differentiation of infected from vaccinated animals.
Luo Y; Li L; Austermann-Busch S; Dong M; Xu J; Shao L; Lei J; Li N; He WR; Zhao B; Li S; Li Y; Liu L; Becher P; Sun Y; Qiu HJ
J Virol Methods; 2015 Sep; 222():22-7. PubMed ID: 26005003
[TBL] [Abstract][Full Text] [Related]
4. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
Aebischer A; Müller M; Hofmann MA
Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics.
Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA
Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022
[TBL] [Abstract][Full Text] [Related]
6. The double-antigen ELISA concept for early detection of E
Meyer D; Fritsche S; Luo Y; Engemann C; Blome S; Beyerbach M; Chang CY; Qiu HJ; Becher P; Postel A
Transbound Emerg Dis; 2017 Dec; 64(6):2013-2022. PubMed ID: 28158921
[TBL] [Abstract][Full Text] [Related]
7. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.
de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ
Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670
[TBL] [Abstract][Full Text] [Related]
8. Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.
van Gennip HG; Bouma A; van Rijn PA; Widjojoatmodjo MN; Moormann RJ
Vaccine; 2002 Feb; 20(11-12):1544-56. PubMed ID: 11858861
[TBL] [Abstract][Full Text] [Related]
9. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections.
Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z
Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
[TBL] [Abstract][Full Text] [Related]
11. Genetically distinct pestiviruses pave the way to improved classical swine fever marker vaccine candidates based on the chimeric pestivirus concept.
Postel A; Becher P
Emerg Microbes Infect; 2020 Dec; 9(1):2180-2189. PubMed ID: 32962557
[TBL] [Abstract][Full Text] [Related]
12. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response.
van Gennip HG; van Rijn PA; Widjojoatmodjo MN; de Smit AJ; Moormann RJ
Vaccine; 2000 Oct; 19(4-5):447-59. PubMed ID: 11027808
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review.
de Smit AJ
Vet Q; 2000 Oct; 22(4):182-8. PubMed ID: 11087126
[TBL] [Abstract][Full Text] [Related]
14. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.
Reimann I; Depner K; Trapp S; Beer M
Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124
[TBL] [Abstract][Full Text] [Related]
15. Multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E.coli as multiple epitope vaccine induces a protective immune response.
Zhou B; Liu K; Jiang Y; Wei JC; Chen PY
Virol J; 2011 Jul; 8():378. PubMed ID: 21801433
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope.
Reimann I; Depner K; Utke K; Leifer I; Lange E; Beer M
Vet Microbiol; 2010 Apr; 142(1-2):45-50. PubMed ID: 19892497
[TBL] [Abstract][Full Text] [Related]
17. Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf".
Henke J; Carlson J; Zani L; Leidenberger S; Schwaiger T; Schlottau K; Teifke JP; Schröder C; Beer M; Blome S
Vaccine; 2018 Jul; 36(29):4181-4187. PubMed ID: 29895502
[TBL] [Abstract][Full Text] [Related]
18. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M
Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658
[TBL] [Abstract][Full Text] [Related]
20. Development of a marker vaccine candidate against classical swine fever based on the live attenuated vaccine C-strain.
Han Y; Xie L; Yuan M; Ma Y; Sun H; Sun Y; Li Y; Qiu HJ
Vet Microbiol; 2020 Aug; 247():108741. PubMed ID: 32768202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
